genedrive plc
("genedrive" or the "Company")
Block Listing Returns
The Company confirms the block listing six monthly return for the period to 31 May 2023.
Name of applicant |
genedrive plc
|
|||
Name of scheme |
2007 Share Option Scheme
|
|||
Period of return: |
From: |
01 December 2022 |
To: |
31 May 2023 |
Balance of unallocated securities under scheme(s) from previous return: |
139,226 shares
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
7,500 shares |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
131,726 shares
|
|||
In order to co-terminate future block listing returns the Company confirms the following returns for the two block listings granted earlier in the month.
Name of applicant |
genedrive plc
|
|||
Name of scheme |
2017 Share Option Scheme
|
|||
Period of return: |
From: |
19 May 2023 |
To: |
31 May 2023 |
Balance of unallocated securities under scheme(s) from previous return: |
1,150,588 shares
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
Nil |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1,150,588 shares
|
|||
Name of applicant |
genedrive plc
|
|||
Name of scheme |
Unapproved Share Option Scheme
|
|||
Period of return: |
From: |
19 May 2023 |
To: |
31 May 2023 |
Balance of unallocated securities under scheme(s) from previous return: |
2,668,144 shares
|
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
Nil |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
2,668,144 shares
|
|||
Name of contact: |
Russ Shaw CFO |
|||
Telephone number of contact: |
+44 (0)161 989 0245 |
|||
For enquires:
genedrive plc |
+44 (0)161 989 0245 |
|
David Budd: CEO / Russ Shaw: CFO |
|
|
|
|
|
|
|
|
Peel Hunt LLP (Nominated Adviser and Joint Broker) |
+44 (0)20 7418 8900 |
|
James Steel / Oliver Duckworth |
|
|
|
|
|
|
|
|
finnCap (Joint Broker) |
+44 (0)20 7220 500 |
|
Geoff Nash / George Dollemore / Nigel Birks / Alice Lane |
|
|
|
|
|
|
|
|
Walbrook PR Ltd (Media Relations & Investor Relations) |
+44 (0)20 7933 8780 or genedrive@walbrookpr.com |
|
Paul McManus / Anna Dunphy |
+44 (0)7980 541 893 / +44 (0)7876 741 001 |
|
|
|
|